Danilo Giffoni de Mello Morais Mata (Danilo Giffoni M M Mata)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Sentinel Lymph Node

Metastatic Breast Cancer

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Danilo Giffoni de Mello Morais Mata, Mary-Beth Rush, Megan Smith-Uffen, Jawaid Younus, Ana Elisa Lohmann, Maureen E Trudeau, Rebecca L Morgan
The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer-A Systematic Review and Meta-Analysis. Current oncology (Toronto, Ont.) 31 (8) (2024)
Danilo Giffoni de Mello Morais Mata, Mary-Beth Rush, Megan Smith-Uffen, Jawaid Younus, Ana Elisa Lohmann, Maureen E Trudeau, Rebecca L Morgan
The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer-A Systematic Review and Meta-Analysis. Current oncology (Toronto, Ont.) 31 (8) (2024)
Danilo Giffoni de Mello Morais Mata, Mary-Beth Rush, Megan Smith-Uffen, Jawaid Younus, Ana Elisa Lohmann, Maureen E Trudeau, Rebecca L Morgan
The Omission of Anthracycline Chemotherapy in Women with Early HER2-Negative Breast Cancer-A Systematic Review and Meta-Analysis. Current oncology (Toronto, Ont.) 31 (8) (2024)
Tian Xiao, Sanji Ali, Danilo Giffoni de Mello Morais Mata, Ana Elisa Lohmann, Phillip S Blanchette
Antibody-Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond-A 2023 Review. Current oncology (Toronto, Ont.) 30 (7) (2023)
Danilo Giffoni de Mello Morais Mata, Rania Chehade, Malek B Hannouf, Jacques Raphael, Phillip Blanchette, Abdullah Al-Humiqani, Monali Ray
Appraisal of Systemic Treatment Strategies in Early HER2-Positive Breast Cancer-A Literature Review. Cancers 15 (17) (2023)
Danilo Giffoni de Mello Morais Mata, Carlos Amir Carmona, Andrea Eisen, Maureen E Trudeau
Appraising Adjuvant Endocrine Therapy in Hormone Receptor Positive HER2-Negative Breast Cancer-A Literature Review. Current oncology (Toronto, Ont.) 29 (7) (2022)